1 |
Greenspan D, Greenspan JS, Conant M, Petersen V, Silverman S Jr, de Souza Y. Oral “hairy” leucoplakia in male homosexuals: evidence of association with both papillomavirus and a herpes-group virus. Lancet 1984;2:831-834.
|
2 |
Mendoza N, Diamantis M, Arora A, et al. Mucocutaneous manifestations of Epstein-Barr virus infection. Am J Clin Dermatol 2008;9:295-305.
DOI
ScienceOn
|
3 |
Pedreira EN, Cardoso CL, Barroso Edo C, Santos JA, Fonseca FP, Taveira LA. Epidemiological and oral manifestations of HIVpositive patients in a specialized service in Brazil. J Appl Oral Sci 2008;16:369-375.
DOI
|
4 |
Greenspan JS, Greenspan D. Oral hairy leukoplakia: diagnosis and management. Oral Surg Oral Med Oral Pathol 1989;67:396-403.
DOI
ScienceOn
|
5 |
Bhandarkar SS, MacKelfresh J, Fried L, Arbiser JL. Targeted therapy of oral hairy leukoplakia with gentian violet. J Am Acad Dermatol 2008;58:711-712.
DOI
ScienceOn
|
6 |
Moura MD, Haddad JP, Senna MI, Ferreira e Ferreira E, Mesquita RA. A new topical treatment protocol for oral hairy leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:611-617.
DOI
ScienceOn
|
7 |
Moura MD, Guimaraes TR, Fonseca LM, de Almeida Pordeus I, Mesquita RA. A random clinical trial study to assess the efficiency of topical applications of podophyllin resin (25%) versus podophyllin resin (25%) together with acyclovir cream (5%) in the treatment of oral hairy leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:64-71.
DOI
ScienceOn
|
8 |
Galvin S, Healy CM. Oral hairy leukoplakia in healthy, immunocompetent individuals. Ir Med J 2014;107:179-180.
|
9 |
Reynolds SJ, Muwonga J. OraQuick ADVANCE rapid HIV-1/2 antibody test. Expert Rev Mol Diagn 2004;4:587-591.
DOI
ScienceOn
|
10 |
Zachary D, Mwenge L, Muyoyeta M, et al. Field comparison of OraQuick ADVANCE rapid HIV-1/2 antibody test and two blood-based rapid HIV antibody tests in Zambia. BMC Infect Dis 2012;12:183.
DOI
|
11 |
Delaney KP, Branson BM, Uniyal A, et al. Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS 2006;20:1655-1660.
DOI
ScienceOn
|
12 |
Wesolowski LG, MacKellar DA, Facente SN, et al; Post-marketing Surveillance Team. Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS 2006;20:1661-1666.
DOI
ScienceOn
|
13 |
Baccaglini L, Atkinson JC, Patton LL, Glick M, Ficarra G, Peterson DE. Management of oral lesions in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103 Suppl:S50.e1-S50.e23.
|
14 |
Gowdey G, Lee RK, Carpenter WM. Treatment of HIV-related hairy leukoplakia with podophyllum resin 25% solution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;79:64-67.
DOI
ScienceOn
|
15 |
Sanchez M, Spielman T, Epstein W, Moy J. Treatment of oral hairy leukoplakia with podophyllin. Arch Dermatol 1992;128:1659.
DOI
|
16 |
Brasileiro CB, Abreu MH, Mesquita RA. Critical review of topical management of oral hairy leukoplakia. World J Clin Cases 2014;2:253-256.
DOI
|